Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted cancer treatments haven’t worked for patients ...
Bio-Sourcing and Zerion Pharma Join Forces to Develop First HER2 Oral Monoclonal Antibody Against Breast Cancer Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results